Partner Dan Shores will speak on the patent landscape for mRNA and lipid nanoparticle technology at the American Intellectual Property Law Association (AIPLA)'s biotechnology committee quarterly call taking place on Tuesday, April 2, 2024. During the meeting, Dan will provide a detailed overview of the mRNA IP and competitive landscape, including the current patent litigation landscape in the space.
To realize the promise of biotechnology in health, energy, environment, and food requires a reliable, global IP system that rewards innovation without inhibiting it and protects investments in new products and new jobs. Biotechnology IP practitioners and companies, however, face very significant challenges in helping the world realize this promise. The overall mission of the AIPLA's Biotechnology Committee is to serve as resource, educator, and advocate for its members, AIPLA, government institutions, and people everywhere so that the promise of biotechnology may be more fully realized globally.
